- Filed
- May 5, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 28, 2025 | 45.93M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $682.18M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $684.6M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $23.3M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $9.41M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $961.9M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $960.63M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $726.21M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $733.14M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.78B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.79B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 43.03M sh |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | $21.07M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.56 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.56 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $6.49M |
| Net Income | Q1 2025 · Mar 31, 2024 | $24.23M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $24.31M |
| Revenue | Q1 2025 · Mar 31, 2024 | $51.37M |